Join us at the Nuclear Medicine Symposium
Radiopharmaceuticals is experiencing rapid growth nationally and is poised for greater investment and breakthroughs in patient care.
The Nuclear Medicine Symposium positions Greater Philadelphia as a hub for innovation at the intersection of science, clinical practice, and industry. Whether you are advancing research, delivering care, commercializing new technologies, or investing in what’s next, this event brings together the voices to translating discovery into impact and accelerating progress.
Speakers for this event include Steve Hahn, Jon Epstein, Mark Mintun, and Jeff Marrazzo, along with Sumit Vermaand others.
Access to this event is by exclusive invitation only and cannot be transferred. Because we anticipate a full house, please confirm your attendance by registering. Only invited partners will be accepted, and others may be placed on the wait list.
1:00pm – Registration & Networking
4:30pm – Cocktail reception in Quorum Lounge
Nuclear Medicine at uCity Square: Avid Pharmaceuticals
Avid Radiopharmaceuticals develops FDA‑approved PET imaging diagnostics that enable early disease detection, monitor treatment response, and support drug development through innovative diagnostic science.